Biologics Under Part D: Coinsurance, Cost Containment And Coverage Overlap
Executive Summary
Coinsurance appears to be the preferred cost-sharing method for biologics in Medicare Part D plans, according to an analysis of plan formularies by "The Pink Sheet."